Skip to main content
Ir a la página de inicio de la Comisión Europea (se abrirá en una nueva ventana)
español es
CORDIS - Resultados de investigaciones de la UE
CORDIS

Translating In Silico NAMs into Regulatory Practice for Medical Devices

Objetivo

iNAMed aims to establish a precedent for integrating in silico New Approach Methodologies (NAMs) into the conformity assessment of medical devices under MDR (EU 2017/745). Although AI-driven computational toxicology has reached high scientific maturity, its regulatory uptake remains limited due to insufficient validation, lack of structured benchmarking and absence of formal integration pathways. The project addresses this gap by transforming validated in silico NAMs into a regulator-ready methodology and demonstrating it through a real industrial reference case – the GlucoSet continuous glucose monitoring sensor for ICU patients.
The project builds on the nQTb prototype forming the core of the QL Materials platform (TRL 4), which predicts genotoxicity (Comet assay), mutagenicity (Micronucleus test) and pro-inflammatory responses (IL-6, TNF-α) for nanoforms of TiO2 and SiO2 in line with OECD QSAR Assessment Framework principles.
Stage 1 advances the system to TRL 5 through structured external validation, benchmarking against ISO 10993-relevant endpoints and formal demonstration of methodological equivalence with accepted testing standards. A regulatory integration framework and roadmap for acceptance will be developed, mapping MDR requirements and defining documentation standards aligned with conformity assessment practice. Stage 2 foresees operational deployment within the GlucoSet development workflow, integrating in silico outputs into technical documentation and progressing toward TRL 7.
By reducing early-stage experimental burden, shortening material optimisation cycles and enhancing human relevance through validation on human-relevant models, iNAMed establishes the foundations for scalable, regulatory-grade digital safety assessment. In the longer term, it creates a building block for digital safety twins capable of simulating material–host interactions before clinical exposure, positioning Europe at the forefront of digital regulatory science.

Ámbito científico (EuroSciVoc)

Palabras clave

Programa(s)

Tema(s)

Régimen de financiación

HORIZON-EIC - HORIZON EIC Grants

Ver todos los proyectos financiados en el marco de este régimen de financiación

Convocatoria de propuestas

(se abrirá en una nueva ventana) HORIZON-EIC-2026-AIC

Ver todos los proyectos financiados en el marco de esta convocatoria

Coordinador

QSAR LAB SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA
Aportación neta de la UEn
€ 300 000,00
Dirección
ALEJA GRUNWALDZKA 103A
80-244 GDANSK
Polonia
Pyme
Sí
Región
Makroregion północny Pomorskie Trójmiejski
Tipo de actividad
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Enlaces
Coste total
Sin datos